Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERASER: Ranibizumab in working individuals with DME
NCT02107131Phase 4Completed
- Sponsor
- California Retina Consultants
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in diabetic macular edema (DME), sponsored by California Retina Consultants. Started Mar 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02107131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107131.